iiinova — where your digital self keeps evolving

Sara Tolaney @stolaney1.bsky.social · 29/03/2025

Thank you so mcuh @stoverlab.bsky.social for the phenomenal keynote lecture-- you have built an incredible translational research infrastructure and team! It was wonderful to have you back in Boston! @dfcibreastonc.bsky.social

091

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 15/01/2025

Don't miss this recent review outlining practical treatment strategies and novel therapies in the PI3K/AKT/mTOR pathway in HR+/HER2- advanced #BreastCancer 🔓 pubmed.ncbi.nlm.nih.gov/39674130/ @antgiordanomd.bsky.social @drtimothyerick.bsky.social @stolaney1.bsky.social @drsarahsammons.bsky.social

0127

Reposted by Sara Tolaney

Marleen Kok, MD PhD, NKI @marleenkok.bsky.social · 07/02/2025

very important (but negative) trial on cdk46i in mTNBC. huge shout-out to @stolaney1.bsky.social and Shom Goel for conducting this trial👍 @oncoalert.bsky.social #bcsm

074

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 13/02/2025

Don't miss this recent Current Oncology Reports review on #AntibodyDrugConjugates in #BreastCancer: The Road Towards Biologically-Informed Selection and Sequencing pubmed.ncbi.nlm.nih.gov/39786525/ @ptarantinomd.bsky.social @ilanaschlam.bsky.social @stolaney1.bsky.social #AnaGarridoCastro

031

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 26/02/2025

Dr. Paolo Tarantino (@ptarantinomd.bsky.social) and Dr. Sara Tolaney (@stolaney1.bsky.social) discuss efforts to create consensus based #BreastCancer Treatment Guidelines, which are meant to encourage uniform, evidence-based practice. Read here ⬇️ physicianresources.dana-farber.org/symposium/br...

011

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 09/12/2024

Join Dr. Sara Tolaney (@stolaney1.bsky.social) tomorrow at #SABCS24 for an insightful #CareerDevelopment session, focused on early funding for research. Dr. Tolaney will discuss the importance of having foundation and community program support. 🗓️ Dec 10th ⏰12:00–1:45 pm CST (1:00 pm EST) 📍Rm 221ABC

082

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 10/12/2024

Dr. Sara Tolaney (@stolaney1.bsky.social) will moderate the #SABCS24 poster spotlight session 3 on novel therapeutics in #BreastCancer on Wed Dec 11th – don’t miss it! 🗓️ Wednesday, December 11th ⏰ 7:00 – 8:30 am CST (8:00 – 9:30 am EST) 📍 Stars at Night 1-2

031

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 10/12/2024

Dr. Sara Tolaney (@stolaney1.bsky.social) offered great tips and strategies for obtaining research funding from foundations and community programs in the #SABCS24 Career Development Session. Biggest take away: Start early! @danafarber.bsky.social

0115

Reposted by Sara Tolaney

Chiara Corti, MD @ccortimd.bsky.social · 13/12/2024

Thank you all for stepping by and chatting with me yesterday. Thanks to @dfcibreastonc.bsky.social , my mentor @stolaney1.bsky.social , and all the co-authors for this great opportunity 😊 #SABCS2024 @sabcs.bsky.social

1102

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 06/12/2024

Meet Dr. Stefania Morganti, an Advanced Fellow at the Breast Oncology Center at @danafarber.bsky.social. Dr. Morganti earned her MD at the University of Pavia and specialized in medical oncology. Her research is aimed at developing patient-centered approaches to advance #BreastCancer treatment.

082

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 05/12/2024

Check out the #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (November 25th- December 1st, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

051

Reposted by Sara Tolaney

Paolo Tarantino, MD @ptarantinomd.bsky.social · 06/12/2024

Make sure to follow @dfcibreastonc.bsky.social for updates on the latest research efforts by DFCI BOC and for periodic research digest with recent news in breast oncology! @stolaney1.bsky.social

1167

Reposted by Sara Tolaney

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 05/12/2024

Dr. Abirami Natarajan and Dr. Sara Tolaney (@stolaney1.bsky.social) discuss adjuvant #ribociclib in this Annals of Oncology editorial. 👀 check it out here: sciencedirect.com/science/arti...

074

Reposted by Sara Tolaney

San Antonio Breast Cancer Symposium @sabcs.bsky.social · 27/11/2024

We are looking forward to this year's San Antonio Breast Cancer Symposium which starts on December 10. Take a look at the full program for this important meeting featuring the latest research on breast cancer. sabcs.org/FullProgram #SABCS24 #breastcancer

04412

Reposted by Sara Tolaney

Tatiana Prowell, MD @tmprowell.bsky.social · 26/11/2024

Link for more info & to access FDA-ASCO Fellows’ Day Workshop application is here: asco.smapply.org/prog/Februar.... Apply by 12/4/24. Hope to see some of you in person or on Zoom for a day of #regulatory science #MedEd, #OncSky! 😃 #MedSky #healthpolicy #mentorship #OncoAlert

asco.smapply.org

February 2025 FDA/ASCO Fellows' Day Workshop - Application Portal

062

Reposted by Sara Tolaney

Ilana Schlam @ilanaschlam.bsky.social · 27/11/2024

Looking forward to #SABCS24 - there is a lot of important research being presented, some to highlight: 🔑 Biomarker analysis of KN522 🔑 EMBER-3 🔑 MARGOT 🔑 SONIA 🔑 EUROPA 🔑 SOLTI VALENTINE 🔑 GeparDouze

0144

Reposted by Sara Tolaney

Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 26/11/2024

We are going to be bringing #SABCS24 updates to #BlueSky too starting Dec 10th! Many great colleagues on here including some amazing advocates. @itsnotpink.bsky.social @janicetnbcmets.bsky.social @oncbrothers.bsky.social @hoperugo.bsky.social ....and others! @sabcs.bsky.social #bcsm

57713